Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
Public Health Sciences Division, Fred Hutchinson Cancer Research Center
Center for Inference & Dynamics of Infectious Disease, Fred Hutchinson Cancer Research Center
Halloran Group, Fred Hutchinson Cancer Research Center
Department of Biostatistics, School of Public Health, University of Washington
She/her/hers
Mexico
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Ira Longini, Alessandro Vespignani, M Halloran
2020 – 2022 Continue Reading Mathematical and Statistical Methods for the Control of Global Infectious Disease Threats
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: Ira Longini, Natalie Dean, Yang Yang, M Halloran
2015 – 2022 Continue Reading Methods for Evaluating Vaccine Efficacy
National Institutes of Health, National Institute of Allergy and Infectious Diseases
People: M Halloran
2011 – 2013 Continue Reading Acquisition and loss of Neisseria meningitidis carriage in households in Mali
National Institutes of Health, National Institute of General Medical Sciences
People: M Halloran
2010 – 2019 Continue Reading Summer Institute in Statistics and Modeling in Infectious Diseases
National Institutes of Health, National Institute of General Medical Sciences
People: Ira Longini, M Halloran
2004 – 2014 Continue Reading Containing Bioterrorist and Emerging Infectious Diseases
Xu J, Halloran ME, Moore M, Zhang L, Hyrien O, Luedtke A, El Sahly HM, Baden LR, Goepfert PA, Gray G, Grinsztejn B, Sobieszczyk ME, Falsey AR, Robinson ST, Garcia NMG, Zhou H, van Dromme I, Truyers C, Hirsch I, Neuzil KM, Corey L, Kublin JG, Follmann D, Janes HE, Gilbert PB, Huang Y. (2026). Association between COVID-19 vaccine efficacy and epidemic force of infection. NPJ vaccines
Barrera-Fuentes GA, Antonioli C, Pavia-Ruz N, Che-Mendoza A, Earnest JT, Kirstein OD, Eb-Cordova AB, Ciau-Carillo KJ, Jabbarzadeh S, Granja-Perez P, Villanueva-Jorge S, Puerta-Guardo H, Collins MH, Ayora-Talavera G, Halloran ME, Longini IM, Dean N, Waller LA, Crisp A, Manrique-Saide P, Vazquez-Prokopec GM, Gomez-Dantes H. (2026). Integrated Surveillance Strategies and Clinical Characteristics of Arboviral Diseases in a Pediatric Cohort in Merida, Mexico, 2021-2023. The American journal of tropical medicine and hygiene, 115(1)
Chen K, Cheng J, Halloran ME, Small DS. (2026). Using case description information to reduce sensitivity to bias for the attributable fraction among the exposed. Journal of the Royal Statistical Society. Series A, (Statistics in Society), 189(3)
Crisp AM, Halloran ME, Hitchings MDT, Longini IM, Dean NE. (2025). Analysis methods for covariate-constrained cluster randomized trials with time-to-event outcomes. BMC medical research methodology, 25(1)
Ajelli M, Muyembe JJ, Touré A, Diallo A, Litvinova M, Merler S, Mulangu S, Bagayoko A, Bah A, Bah I, Barry A, Barry F, Chérif M, Condé D, Diallo AA, Diallo F, Diakité M, Doré K, Mapan KA, Koundouno T, Onivogui PK, Lamah F, Maneno H, Nomou A, Sekouba K, Sani I, Soumah A, Sy MM, Gsell PS, Halloran ME, Henao-Restrepo AM, Fall IS, Ryan MJ, Salama P, Vespignani A, Longini IM Jr.. (2025). Vaccination Strategies for Ebola in the Democratic Republic of Congo: The WHO-Ebola Modeling Collaboration. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Dean NE, Crisp AM, Che-Mendoza A, Kirstein OD, Barrera-Fuentes GA, Earnest JT, Puerta-Guardo HN, Collins MH, Pavia-Ruz N, Ayora-Talavera G, González-Olvera G, Medina-Barreiro A, Bibiano-Marín W, Jabbarzadeh S, Halloran ME, Longini IM Jr., Lenhart A, Waller LA, Correa-Morales F, Palacio-Vargas J, Gomez-Dantes H, Manrique-Saide P, Vazquez-Prokopec GM. (2025). Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases. The New England journal of medicine, 393(14)
Tsang TK, Rojas DP, Xu F, Xu Y, Zhu X, Halloran ME, Longini IM, Yang Y. (2025). Estimating transmissibility of Zika virus in Colombia in the presence of surveillance bias. Nature communications, 16(1)
Lee T, Buchanan AL, Katenka N, Forastiere L, Halloran ME, Nikolopoulos G. (2025). Assessing spillover effects: Handling missing outcomes in network-based studies. Statistical methods in medical research
Andrews LIB, Halloran ME, Neuzil KM, van der Laan L, Huang Y, Andriesen J, Patel M, Fisher LH, Janes H, Rouphael N, Walsh SR, Theodore DA, Tieu HV, Sobieszczyk M, El Sahly HM, Baden LR, Falsey AR, Campbell TB, Kelley CF, Healy CM, Immergluck L, Luft B, Hirsch I, de Bruyn G, Truyers C, Priddy F, Sumner KM, Flannery B, Follmann D, Gilbert PB, . (2025). Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data: A Secondary Cross-Protocol Analysis of 5 Randomized Clinical Trials. JAMA network open, 8(5)
Halloran ME. (2025). Designs for Vaccine Studies. Annual review of statistics and its application, (12)
Dean NE, Halloran ME, Zarnitsyna VI. (2024). Poor vaccine responders mask the true trend in vaccine effectiveness against progression to severe disease. Vaccine, 43(Pt 2)
Earnest JT, Kirstein OD, Mendoza AC, Barrera-Fuentes GA, Puerta-Guardo H, Parra-Cardeña M, Yam-Trujillo K, Collins MH, Pavia-Ruz N, Ayora-Talavera G, Gonzalez-Olvera G, Medina-Barreiro A, Bibiano-Marin W, Lenhart A, Halloran ME, Longini I, Dean N, Waller LA, Crisp AM, Correa-Morales F, Palacio-Vargas J, Granja-Perez P, Villanueva S, Delfın-Gonzalez H, Gomez-Dantes H, Manrique-Saide P, Vazquez-Prokopec GM. (2024). The TIRS trial: Enrollment procedures and baseline characterization of a pediatric cohort to quantify the epidemiologic impact of targeted indoor residual spraying on Aedes-borne viruses in Merida, Mexico. PloS one, 19(9)
Huo Y, Yang Y, Halloran ME, Longini IM Jr., Dean NE. (2024). Hypothesis testing and sample size considerations for the test-negative design. BMC medical research methodology, 24(1)
Halloran ME, Struchiner CJ. (2024). Invited Commentary: Thirty-five Years of Leaky Vaccines. American journal of epidemiology
Puleo J, Buchanan A, Katenka N, Halloran ME, Friedman SR, Nikolopoulos G. (2024). Assessing Spillover Effects of Medications for Opioid Use Disorder on HIV Risk Behaviors among a Network of People Who Inject Drugs. Stats, 7(2)
Huo Y, Yang Y, Halloran ME, Longini IM Jr., Dean NE. (2023). Hypothesis testing and sample size considerations for the test-negative design. Research square
Madewell ZJ, Yang Y, Longini IM Jr., Halloran ME, Vespignani A, Dean NE. (2023). Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants. BMC infectious diseases, 23(1)
Crisp AM, Halloran ME, Longini IM, Vazquez-Prokopec G, Dean NE. (2023). Covariate-constrained randomization with cluster selection and substitution. Clinical trials (London, England), 20(3)
Rane MS, Wakefield J, Rohani P, Halloran ME. (2023). Association between pertussis vaccination coverage and other sociodemographic factors and pertussis incidence using surveillance data. Epidemics, (44)
Buchanan AL, Katenka N, Lee Y, Wu J, Pantavou K, Friedman SR, Halloran ME, Marshall BDL, Forastiere L, Nikolopoulos GK. (2023). Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs. Pathogens (Basel, Switzerland), 12(2)
Lee Y, Buchanan AL, Ogburn EL, Friedman SR, Halloran ME, Katenka NV, Wu J, Nikolopoulos GK. (2023). Finding influential subjects in a network using a causal framework. Biometrics
Rogers JH, Cox SN, Link AC, Nwanne G, Han PD, Pfau B, Chow EJ, Wolf CR, Boeckh M, Hughes JP, Halloran ME, Uyeki TM, Shim MM, Duchin J, Englund JA, Mosites E, Rolfes MA, Starita LA, Chu HY. (2023). Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study. Epidemiology and infection, (151)
Gozzi N, Chinazzi M, Dean NE, Longini IM Jr., Halloran ME, Perra N, Vespignani A. (2023). Estimating the impact of COVID-19 vaccine inequities: a modeling study. Nature communications, 14(1)
Prasad PV, Steele MK, Reed C, Meyers LA, Du Z, Pasco R, Alfaro-Murillo JA, Lewis B, Venkatramanan S, Schlitt J, Chen J, Orr M, Wilson ML, Eubank S, Wang L, Chinazzi M, Pastore Y Piontti A, Davis JT, Halloran ME, Longini I, Vespignani A, Pei S, Galanti M, Kandula S, Shaman J, Haw DJ, Arinaminpathy N, Biggerstaff M. (2023). Multimodeling approach to evaluating the efficacy of layering pharmaceutical and nonpharmaceutical interventions for influenza pandemics. Proceedings of the National Academy of Sciences of the United States of America, 120(28)
Zhang B, Hudgens MG, Halloran ME. Propensity Score in the Face of Interference: Discussion of. Observational studies, 9(1)
Lee T, Buchanan AL, Katenka NV, Forastiere L, Halloran ME, Friedman SR, Nikolopoulos G. (2023). Estimating Causal Effects of HIV Prevention Interventions with Interference in Network-based Studies among People Who Inject Drugs. The annals of applied statistics, 17(3)
Madewell ZJ, Yang Y, Longini IM Jr., Halloran ME, Dean NE. (2022). Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis. JAMA network open, 5(4)
Buchanan AL, Park CJ, Bessey S, Goedel WC, Murray EJ, Friedman SR, Halloran ME, Katenka NV, Marshall BDL. (2022). Spillover Benefit of Pre-Exposure Prophylaxis for HIV Prevention: Evaluating the Importance of Effect Modification using an Agent-Based Model. Epidemiology and infection
Longini IM, Yang Y, Fleming TR, Muñoz-Fontela C, Wang R, Ellenberg SS, Qian G, Halloran ME, Nason M, Gruttola V, Mulangu S, Huang Y, Donnelly CA, Henao Restrepo AM. (2022). A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats. Clinical trials (London, England)
Johnson PLF, Bergstrom CT, Regoes RR, Longini IM, Halloran ME, Antia R. (2022). Evolutionary consequences of delaying intervention for monkeypox. Lancet
Gozzi N, Chinazzi M, Dean NE, Longini IM Jr., Halloran ME, Perra N, Vespignani A. (2022). Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study. medRxiv : the preprint server for health sciences
Aleta A, Martín-Corral D, Bakker MA, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM Jr., Pentland A, Vespignani A, Moreno Y, Moro E. (2022). Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas. Proceedings of the National Academy of Sciences of the United States of America, 119(26)
Dean NE, Halloran ME. (2022). Protecting the herd with vaccination. Science (New York, N.Y.), 375(6585)
Aroke H, Buchanan A, Katenka N, Crawford FW, Lee T, Halloran ME, Latkin C. (2022). Evaluating the Mediating Role of Recall of Intervention Knowledge in the Relationship Between a Peer-Driven Intervention and HIV Risk Behaviors Among People Who Inject Drugs. AIDS and behavior
Potter GE, Carnegie NB, Sugimoto JD, Diallo A, Victor JC, Neuzil KM, Halloran ME. (2022). Using social contact data to improve the overall effect estimate of a cluster-randomized influenza vaccination program in Senegal. Journal of the Royal Statistical Society. Series C, Applied statistics, 71(1)
Chakladar S, Rosin SP, Hudgens MG, Halloran ME, Clemens JD, Ali M, Emch ME. (2021). Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring. Biometrics
Davis JT, Chinazzi M, Perra N, Mu K, Piontti APY, Ajelli M, Dean NE, Gioannini C, Litvinova M, Merler S, Rossi L, Sun K, Xiong X, Halloran ME, Longini IM Jr., Viboud C, Vespignani A. (2021). Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States. medRxiv : the preprint server for health sciences
Davis JT, Chinazzi M, Perra N, Mu K, Pastore Y Piontti A, Ajelli M, Dean NE, Gioannini C, Litvinova M, Merler S, Rossi L, Sun K, Xiong X, Longini IM Jr., Halloran ME, Viboud C, Vespignani A. (2021). Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave. Nature
Antia R, Halloran ME. (2021). Transition to endemicity: Understanding COVID-19. Immunity
Halloran ME. (2021). Discussion on "Estimating vaccine efficacy over time after a randomized study is unblinded" by Anastasios A. Tsiatis and Marie Davidian. Biometrics
Rane MS, Halloran ME. (2021). Estimating population-level effects of the acellular pertussis vaccine using routinely collected immunization data. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Feldstein LR, Ferdinands JM, Self WH, Randolph AG, Aboodi M, Baughman AH, Brown SM, Exline MC, Files DC, Gibbs K, Ginde AA, Gong MN, Grijalva CG, Halasa N, Khan A, Lindsell CJ, Newhams M, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub J, Talbot HK, Halloran ME, Patel M. (2021). Modeling the impacts of clinical influenza testing on influenza vaccine effectiveness estimates. The Journal of infectious diseases
Li F, Li YY, Liu MJ, Fang LQ, Dean NE, Wong GWK, Yang XB, Longini I, Halloran ME, Wang HJ, Liu PL, Pang YH, Yan YQ, Liu S, Xia W, Lu XX, Liu Q, Yang Y, Xu SQ. (2021). Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. The Lancet. Infectious diseases
Mistry D, Litvinova M, Pastore Y Piontti A, Chinazzi M, Fumanelli L, Gomes MFC, Haque SA, Liu QH, Mu K, Xiong X, Halloran ME, Longini IM Jr., Merler S, Ajelli M, Vespignani A. (2021). Inferring high-resolution human mixing patterns for disease modeling. Nature communications, 12(1)
Halloran ME. (2021). Comment on AIDS and COVID-19: A tale of two pandemics and the role of statisticians. Statistics in medicine, 40(11)
Katzelnick LC, Zambrana JV, Elizondo D, Collado D, Garcia N, Arguello S, Mercado JC, Miranda T, Ampie O, Mercado BL, Narvaez C, Gresh L, Binder RA, Ojeda S, Sanchez N, Plazaola M, Latta K, Schiller A, Coloma J, Carrillo FB, Narvaez F, Halloran ME, Gordon A, Kuan G, Balmaseda A, Harris E. (2021). Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term. Science translational medicine, 13(614)
Madewell ZJ, Dean NE, Berlin JA, Coplan PM, Davis KJ, Struchiner CJ, Halloran ME. (2021). Challenges of evaluating and modelling vaccination in emerging infectious diseases. Epidemics, (37)
Rane MS, Rohani P, Halloran ME. (2021). Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington. Vaccine
Madewell ZJ, Pastore Y Piontti A, Zhang Q, Burton N, Yang Y, Longini IM, Halloran ME, Vespignani A, Dean NE. (2021). Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic. Clinical trials (London, England)
Madewell ZJ, Yang Y, Longini IM Jr., Halloran ME, Dean NE. (2021). Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis. JAMA network open, 4(8)
Rane MS, Rohani P, Halloran ME. (2021). Association of Diphtheria-Tetanus-Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children. JAMA network open, 4(8)
Madewell ZJ, Yang Y, Longini IM Jr., Halloran ME, Dean NE. (2020). Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate. medRxiv : the preprint server for health sciences
Madewell ZJ, Yang Y, Longini IM Jr., Halloran ME, Dean NE. (2020). Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis. JAMA network open, 3(12)
Buchanan AL, Bessey S, Goedel WC, King M, Murray EJ, Friedman S, Halloran ME, Marshall BDL. (2020). Disseminated Effects in Agent Based Models: A Potential Outcomes Framework and Application to Inform Pre-Exposure Prophylaxis Coverage Levels for HIV Prevention. American journal of epidemiology
Katzelnick LC, Narvaez C, Arguello S, Lopez Mercado B, Collado D, Ampie O, Elizondo D, Miranda T, Bustos Carillo F, Mercado JC, Latta K, Schiller A, Segovia-Chumbez B, Ojeda S, Sanchez N, Plazaola M, Coloma J, Halloran ME, Premkumar L, Gordon A, Narvaez F, de Silva AM, Kuan G, Balmaseda A, Harris E. (2020). Zika virus infection enhances future risk of severe dengue disease. Science (New York, N.Y.), 369(6507)
Lee EC, Chao DL, Lemaitre JC, Matrajt L, Pasetto D, Perez-Saez J, Finger F, Rinaldo A, Sugimoto JD, Halloran ME, Longini IM Jr., Ternier R, Vissieres K, Azman AS, Lessler J, Ivers LC. (2020). Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study. The Lancet. Global health, 8(8)
Feldstein LR, Self WH, Ferdinands JM, Randolph AG, Aboodi M, Baughman AH, Brown SM, Exline MC, Files DC, Gibbs K, Ginde AA, Gong MN, Grijalva CG, Halasa N, Khan A, Lindsell CJ, Newhams M, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub J, Talbot HK, Halloran ME, Patel M,. (2020). Incorporating real-time influenza detection into the test-negative design for estimating influenza vaccine effectiveness: The real-time test-negative design (rtTND). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, Li M, Zheng W, Yi L, Chen X, Wu Q, Liang Y, Wang X, Yang J, Sun K, Longini IM Jr., Halloran ME, Wu P, Cowling BJ, Merler S, Viboud C, Vespignani A, Ajelli M, Yu H. (2020). Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study. medRxiv : the preprint server for health sciences
Hladish TJ, Pearson CAB, Toh KB, Rojas DP, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM Jr.. (2020). Designing effective control of dengue with combined interventions. Proceedings of the National Academy of Sciences of the United States of America
Halloran ME, Longini IM, Gilbert PB. (2020). Designing a Study of Correlates of Risk for Ebola Vaccination. American journal of epidemiology
Buckee CO, Balsari S, Chan J, Crosas M, Dominici F, Gasser U, Grad YH, Grenfell B, Halloran ME, Kraemer MUG, Lipsitch M, Metcalf CJE, Meyers LA, Perkins TA, Santillana M, Scarpino SV, Viboud C, Wesolowski A, Schroeder A. (2020). Aggregated mobility data could help fight COVID-19. Science (New York, N.Y.)
Aleta A, Martin-Corral D, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM, Merler S, Pentland A, Vespignani A, Moro E, Moreno Y. (2020). Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic. medRxiv : the preprint server for health sciences
Ulrich AK, McKearnan SB, Lammert S, Wolfson J, Pletcher J, Halloran ME, Basta NE. (2020). Validity of university students' self-reported vaccination status after a meningococcal B outbreak. Journal of American college health : J of ACH
Dean NE, Halloran ME, Longini IM Jr.. (2020). Temporal Confounding in the Test Negative Design. American journal of epidemiology
Dean NE, Pastore Y Piontti A, Madewell ZJ, Cummings DAT, Hitchings MDT, Joshi K, Kahn R, Vespignani A, Halloran ME, Longini IM Jr.. (2020). Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials. Vaccine
Ogburn EL, Bierer BE, Brookmeyer R, Choirat C, Dean NE, De Gruttola V, Ellenberg SS, Halloran ME, Hanley DF Jr., Lee JK, Wang R, Scharfstein DO. (2020). Aggregating data from COVID-19 trials. Science (New York, N.Y.), 368(6496)
Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, Pastore Y Piontti A, Rossi L, Sun K, Viboud C, Xiong X, Yu H, Halloran ME, Longini IM Jr., Vespignani A. (2020). The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak. medRxiv : the preprint server for health sciences
Magaret AS, Jacob ST, Halloran ME, Guthrie KA, Magaret CA, Johnston C, Simon NR, Wald A. (2020). Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions. Annals of internal medicine
Niang MN, Sugimoto JD, Diallo A, Diarra B, Ortiz JR, Lewis KDC, Lafond KE, Halloran ME, Widdowson MA, Neuzil KM, Victor JC. (2020). Estimates of inactivated influenza vaccine effectiveness among children in Senegal: results from two consecutive cluster-randomized controlled trials in 2010 and 2011. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, Pastore Y Piontti A, Mu K, Rossi L, Sun K, Viboud C, Xiong X, Yu H, Halloran ME, Longini IM Jr., Vespignani A. (2020). The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science (New York, N.Y.), 368(6489)
Manrique-Saide P, Dean NE, Halloran ME, Longini IM, Collins MH, Waller LA, Gomez-Dantes H, Lenhart A, Hladish TJ, Che-Mendoza A, Kirstein OD, Romer Y, Correa-Morales F, Palacio-Vargas J, Mendez-Vales R, Pérez PG, Pavia-Ruz N, Ayora-Talavera G, Vazquez-Prokopec GM. (2020). The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico. Trials, 21(1)
Davis JT, Chinazzi M, Perra N, Mu K, Piontti APY, Ajelli M, Dean NE, Gioannini C, Litvinova M, Merler S, Rossi L, Sun K, Xiong X, Halloran ME, Longini IM Jr., Viboud C, Vespignani A. (2020). Estimating the establishment of local transmission and the cryptic phase of the COVID-19 pandemic in the USA. medRxiv : the preprint server for health sciences
Aleta A, Martín-Corral D, Pastore Y Piontti A, Ajelli M, Litvinova M, Chinazzi M, Dean NE, Halloran ME, Longini IM Jr., Merler S, Pentland A, Vespignani A, Moro E, Moreno Y. (2020). Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19. Nature human behaviour
Kilpatrick KW, Hudgens MG, Halloran ME. (2020). Estimands and inference in cluster-randomized vaccine trials. Pharmaceutical statistics
Wenzel NS, Atkins KE, van Leeuwen E, Halloran ME, Baguelin M. (2020). Cost-effectiveness of live-attenuated influenza vaccination among school-age children. Vaccine
Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, Li M, Zheng W, Yi L, Chen X, Wu Q, Liang Y, Wang X, Yang J, Sun K, Longini IM Jr., Halloran ME, Wu P, Cowling BJ, Merler S, Viboud C, Vespignani A, Ajelli M, Yu H. (2020). Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. The Lancet. Infectious diseases
Dean NE, Gsell PS, Brookmeyer R, Crawford FW, Donnelly CA, Ellenberg SS, Fleming TR, Halloran ME, Horby P, Jaki T, Krause PR, Longini IM, Mulangu S, Muyembe-Tamfum JJ, Nason MC, Smith PG, Wang R, Henao-Restrepo AM, De Gruttola V. (2020). Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. The New England journal of medicine, 382(14)
Chinazzi Matteo, Davis Jessica T, Gioannini Corrado, Litvinova Maria, Pastore Y Piontti Ana, Rossi Luca, Xiong Xinyue, Halloran M Elizabeth, Longini Ira M, Vespignani Alessandro. (2019). Preliminary assessment of the International Spreading Risk Associated with the 2019 novel Coronavirus (2019-nCoV) outbreak in Wuhan City
Feldstein LR, Ellis EM, Rowhani-Rahbar A, Hennessey MJ, Staples JE, Halloran ME, Weaver MR. (2019). Estimating the cost of illness and burden of disease associated with the 2014-2015 chikungunya outbreak in the U.S. Virgin Islands. PLoS neglected tropical diseases, 13(7)
Diallo A, Diop OM, Diop D, Niang MN, Sugimoto JD, Ortiz JR, Faye EHA, Diarra B, Goudiaby D, Lewis KDC, Emery SL, Zangeneh SZ, Lafond KE, Sokhna C, Halloran ME, Widdowson MA, Neuzil KM, Victor JC. (2019). Effectiveness of Seasonal Influenza Vaccination in Children in Senegal During a Year of Vaccine Mismatch: A Cluster-randomized Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69(10)
Tsang TK, Ghebremariam SL, Gresh L, Gordon A, Halloran ME, Katzelnick LC, Rojas DP, Kuan G, Balmaseda A, Sugimoto J, Harris E, Longini IM Jr., Yang Y. (2019). Effects of infection history on dengue virus infection and pathogenicity. Nature communications, 10(1)
Matrajt L, Halloran ME, Antia R. (2019). Reply to Lindsey, Höschler and de Silva. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Schwartz LM, Zaman K, Yunus M, Basunia AH, Faruque ASG, Ahmed T, Rahman M, Sugimoto JD, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC. (2019). Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69(12)
Basta NE, Halloran ME. (2019). Evaluating the Effectiveness of Vaccines Using a Regression Discontinuity Design. American journal of epidemiology, 188(6)
Black A, Moncla LH, Laiton-Donato K, Potter B, Pardo L, Rico A, Tovar C, Rojas DP, Longini IM, Halloran ME, Peláez-Carvajal D, Ramírez JD, Mercado-Reyes M, Bedford T. (2019). Genomic epidemiology supports multiple introductions and cryptic transmission of Zika virus in Colombia. BMC infectious diseases, 19(1)
Matrajt L, Halloran ME, Antia R. (2019). Successes and failures of the live-attenuated influenza vaccine: can we do better?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Potter GE, Wong J, Sugimoto J, Diallo A, Victor JC, Neuzil K, Halloran ME. (2019). Networks of face-to-face social contacts in Niakhar, Senegal. PLoS One, 14(8)
Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM. (2019). Design of vaccine efficacy trials during public health emergencies. Science translational medicine, 11(499)
Hladish TJ, Pearson CAB, Patricia Rojas D, Gomez-Dantes H, Halloran ME, Vazquez-Prokopec GM, Longini IM. (2018). Forecasting the effectiveness of indoor residual spraying for reducing dengue burden. PLoS neglected tropical diseases, 12(6)
Rojas DP, Barrera-Fuentes GA, Pavia-Ruz N, Salgado-Rodriguez M, Che-Mendoza A, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gomez-Dantes H. (2018). Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up. PLoS neglected tropical diseases, 12(11)
Pavía-Ruz N, Barrera-Fuentes GA, Villanueva-Jorge S, Che-Mendoza A, Campuzano-Rincón JC, Manrique-Saide P, Rojas DP, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gómez-Dantés H. (2018). Dengue seroprevalence in a cohort of schoolchildren and their siblings in Yucatan, Mexico (2015-2016). PLoS neglected tropical diseases, 12(11)
Tsang TK, Chen TM, Longini IM Jr., Halloran ME, Wu Y, Yang Y. (2018). Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China. Epidemiology (Cambridge, Mass.), 29(5)
Bisanzio D, Dzul-Manzanilla F, Gomez-Dantes H, Pavia-Ruz N, Hladish TJ, Lenhart A, Palacio-Vargas J, González Roldan JF, Correa-Morales F, Sánchez-Tejeda G, Kuri Morales P, Manrique-Saide P, Longini IM, Halloran ME, Vazquez-Prokopec GM. (2018). Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico. PLoS neglected tropical diseases, 12(3)
Dean NE, Halloran ME, Longini IM. (2018). Design of vaccine trials during outbreaks with and without a delayed vaccination comparator. The annals of applied statistics, 12(1)
Zarnitsyna VI, Bulusheva I, Handel A, Longini IM, Halloran ME, Antia R. (2018). Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks. PloS one, 13(6)
Pavía-Ruz N, Diana Patricia Rojas, Salha Villanueva, Granja P, Balam-May A, Longini IM, Halloran ME, Manrique-Saide P, Gómez-Dantés H. (2018). Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico. The American journal of tropical medicine and hygiene, 98(4)
Fong Y, Halloran ME, Park JK, Marks F, Clemens JD, Chao DL. (2018). Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial. BMC infectious diseases, 18(1)
Sun K, Zhang Q, Pastore-Piontti A, Chinazzi M, Mistry D, Dean NE, Rojas DP, Merler S, Poletti P, Rossi L, Halloran ME, Longini IM Jr., Vespignani A. (2018). Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic. BMC medicine, 16(1)
Pasin C, Halloran ME, Gilbert PB, Langevin E, Ochiai RL, Pitisuttithum P, Capeding MR, Carrasquilla G, Frago C, Cortés M, Chambonneau L, Moodie Z. (2018). Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease. PloS one, 13(12)
Gabriel EE, Sachs MC, Daniels MJ, Halloran ME. (2019). Optimizing and evaluating biomarker combinations as trial-level general surrogates. Statistics in medicine, 38(7)
Feldstein LR, Rowhani-Rahbar A, Staples JE, Halloran ME, Ellis EM. (2018). An Assessment of Household and Individual-Level Mosquito Prevention Methods during the Chikungunya Virus Outbreak in the United States Virgin Islands, 2014-2015. The American journal of tropical medicine and hygiene, 98(3)
Halloran ME, Hudgens MG. (2018). Comment on Laber et al. Journal of the Royal Statistical Society. Series C, Applied statistics, 67(4)
Yang Y, Meng Y, Halloran ME, Longini IM Jr.. (2018). Reply to Aguiar and Stollenwerk. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(4)
Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, Cooper BS, DeGruttola V, Hughes JP, Lessler J, Lofgren ET, Longini IM, Onnela JP, Özler B, Seage GR, Smith TA, Vespignani A, Vynnycky E, Lipsitch M. (2017). Simulations for designing and interpreting intervention trials in infectious diseases. BMC medicine, 15(1)
Zhang Q, Sun K, Chinazzi M, Pastore Y Piontti A, Dean NE, Rojas DP, Merler S, Mistry D, Poletti P, Rossi L, Bray M, Halloran ME, Longini IM Jr., Vespignani A. (2017). Spread of Zika virus in the Americas. Proceedings of the National Academy of Sciences of the United States of America, 114(22)
Metsky HC, Matranga CB, Wohl S, Schaffner SF, Freije CA, Winnicki SM, West K, Qu J, Baniecki ML, Gladden-Young A, Lin AE, Tomkins-Tinch CH, Ye SH, Park DJ, Luo CY, Barnes KG, Shah RR, Chak B, Barbosa-Lima G, Delatorre E, Vieira YR, Paul LM, Tan AL, Barcellona CM, Porcelli MC, Vasquez C, Cannons AC, Cone MR, Hogan KN, Kopp EW, Anzinger JJ, Garcia KF, Parham LA, Ramírez RMG, Montoya MCM, Rojas DP, Brown CM, Hennigan S, Sabina B, Scotland S, Gangavarapu K, Grubaugh ND, Oliveira G, Robles-Sikisaka R, Rambaut A, Gehrke L, Smole S, Halloran ME, Villar L, Mattar S, Lorenzana I, Cerbino-Neto J, Valim C, Degrave W, Bozza PT, Gnirke A, Andersen KG, Isern S, Michael SF, Bozza FA, Souza TML, Bosch I, Yozwiak NL, MacInnis BL, Sabeti PC. (2017). Zika virus evolution and spread in the Americas. Nature, 546(7658)
Feldstein LR, Rowhani-Rahbar A, Staples JE, Weaver MR, Halloran ME, Ellis EM. (2017). Persistent Arthralgia Associated with Chikungunya Virus Outbreak, US Virgin Islands, December 2014-February 2016. Emerging infectious diseases, 23(4)
Halloran ME, Hudgens MG. (2018). Estimating population effects of vaccination using large, routinely collected data. Statistics in medicine, 37(2)
Yang Y, Meng Y, Halloran ME, Longini IM Jr.. (2018). Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 66(2)
Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E. (2017). Antibody-dependent enhancement of severe dengue disease in humans. Science (New York, N.Y.), 358(6365)
Gabriel EE, Sachs MC, Halloran ME. (2018). Evaluation and comparison of predictive individual-level general surrogates. Biostatistics (Oxford, England), 19(3)
Koepke AA, Longini IM Jr., Halloran ME, Wakefield J, Minin VN. (2016). PREDICTIVE MODELING OF CHOLERA OUTBREAKS IN BANGLADESH. The annals of applied statistics, 10(2)
Kenah E, Britton T, Halloran ME, Longini IM Jr.. (2016). Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees. PLoS computational biology, 12(4)
Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM Jr., Halloran ME, Vespignani A. (2016). Containing Ebola at the Source with Ring Vaccination. PLoS neglected tropical diseases, 10(11)
Hladish TJ, Pearson CA, Chao DL, Rojas DP, Recchia GL, Gómez-Dantés H, Halloran ME, Pulliam JR, Longini IM. (2016). Projected Impact of Dengue Vaccination in Yucatán, Mexico. PLoS neglected tropical diseases, 10(5)
Halloran ME, Hudgens MG. (2016). Dependent Happenings: A Recent Methodological Review. Current epidemiology reports, 3(4)
Schwartz LM, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC. (2017). Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design. Vaccine, 35(1)
Rojas DP, Dean NE, Yang Y, Kenah E, Quintero J, Tomasi S, Ramirez EL, Kelly Y, Castro C, Carrasquilla G, Halloran ME, Longini IM. (2016). The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 21(28)
Feldstein LR, Ellis EM, Rowhani-Rahbar A, Halloran ME, Ellis BR. (2016). The First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014-2015. The American journal of tropical medicine and hygiene, 95(4)
Ajelli M, Merler S, Fumanelli L, Pastore Y Piontti A, Dean NE, Longini IM Jr., Halloran ME, Vespignani A. (2016). Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis. BMC medicine, 14(1)
Dean NE, Halloran ME, Yang Y, Longini IM. (2016). Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62(10)
Gabriel EE, Daniels MJ, Halloran ME. (2016). Comparing biomarkers as trial level general surrogates. Biometrics, 72(4)
Fang LQ, Yang Y, Jiang JF, Yao HW, Kargbo D, Li XL, Jiang BG, Kargbo B, Tong YG, Wang YW, Liu K, Kamara A, Dafae F, Kanu A, Jiang RR, Sun Y, Sun RX, Chen WJ, Ma MJ, Dean NE, Thomas H, Longini IM Jr., Halloran ME, Cao WC. (2016). Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone. Proceedings of the National Academy of Sciences of the United States of America, 113(16)
Matrajt L, Britton T, Halloran ME, Longini IM Jr.. (2015). One versus two doses: What is the best use of vaccine in an influenza pandemic?. Epidemics, (13)
Lessler J, Edmunds WJ, Halloran ME, Hollingsworth TD, Lloyd AL. (2015). Seven challenges for model-driven data collection in experimental and observational studies. Epidemics, (10)
Zhou J, Chu H, Hudgens MG, Halloran ME. (2016). A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes. Statistics in medicine, 35(1)
Schwartz LM, Halloran ME, Durbin AP, Longini IM Jr.. (2015). The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine, 33(29)
Merler S, Ajelli M, Fumanelli L, Gomes MF, Piontti AP, Rossi L, Chao DL, Longini IM Jr., Halloran ME, Vespignani A. (2015). Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis. The Lancet. Infectious diseases, 15(2)
Yang Y, Zhang Y, Fang L, Halloran ME, Ma M, Liang S, Kenah E, Britton T, Chen E, Hu J, Tang F, Cao W, Feng Z, Longini IM Jr.. (2015). Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 20(10)
Chao DL, Park JK, Marks F, Ochiai RL, Longini IM, Halloran ME. (2015). The contribution of neighbours to an individual's risk of typhoid outcome. Epidemiology and infection, 143(16)
Lipsitch M, Eyal N, Halloran ME, Hernán MA, Longini IM, Perencevich EN, Grais RF. (2015). Vaccine testing. Ebola and beyond. Science (New York, N.Y.), 348(6230)
VanderWeele TJ, Tchetgen Tchetgen EJ, Halloran ME. (2014). Interference and Sensitivity Analysis. Statistical science : a review journal of the Institute of Mathematical Statistics, 29(4)
Sugimoto JD, Koepke AA, Kenah EE, Halloran ME, Chowdhury F, Khan AI, LaRocque RC, Yang Y, Ryan ET, Qadri F, Calderwood SB, Harris JB, Longini IM Jr.. (2014). Household Transmission of Vibrio cholerae in Bangladesh. PLoS neglected tropical diseases, 8(11)
Dimitrov DT, Troeger C, Halloran ME, Longini IM, Chao DL. (2014). Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study. PLoS neglected tropical diseases, 8(12)
Yang Y, Halloran ME, Chen Y, Kenah E. (2014). A pathway EM-algorithm for estimating vaccine efficacy with a non-monotone validation set. Biometrics, 70(3)
Halloran ME, Vespignani A, Bharti N, Feldstein LR, Alexander KA, Ferrari M, Shaman J, Drake JM, Porco T, Eisenberg JN, Del Valle SY, Lofgren E, Scarpino SV, Eisenberg MC, Gao D, Hyman JM, Eubank S, Longini IM Jr.. (2014). Ebola: mobility data. Science (New York, N.Y.), 346(6208)
Poletto C, Gomes MF, Pastore y Piontti A, Rossi L, Bioglio L, Chao DL, Longini IM, Halloran ME, Colizza V, Vespignani A. (2014). Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 19(42)
Lofgren ET, Halloran ME, Rivers CM, Drake JM, Porco TC, Lewis B, Yang W, Vespignani A, Shaman J, Eisenberg JN, Eisenberg MC, Marathe M, Scarpino SV, Alexander KA, Meza R, Ferrari MJ, Hyman JM, Meyers LA, Eubank S. (2014). Opinion: Mathematical models: a key tool for outbreak response. Proceedings of the National Academy of Sciences of the United States of America, 111(51)
Halloran ME, Longini IM Jr.. (2014). Emerging, evolving, and established infectious diseases and interventions. Science (New York, N.Y.), 345(6202)
Tran CH, Sugimoto JD, Pulliam JR, Ryan KA, Myers PD, Castleman JB, Doty R, Johnson J, Stringfellow J, Kovacevich N, Brew J, Cheung LL, Caron B, Lipori G, Harle CA, Alexander C, Yang Y, Longini IM Jr., Halloran ME, Morris JG Jr., Small PA Jr.. (2014). School-located influenza vaccination reduces community risk for influenza and influenza-like illness emergency care visits. PloS one, 9(12)
Gomes MF, Pastore Y Piontti A, Rossi L, Chao D, Longini I, Halloran ME, Vespignani A. (2014). Assessing the international spreading risk associated with the 2014 west african ebola outbreak. PLoS currents, (6)
Chao DL, Longini IM Jr., Halloran ME. (2013). The effects of vector movement and distribution in a mathematical model of dengue transmission. PLoS One, 8(10)
Matrajt L, Halloran ME, Longini IM Jr.. (2013). Optimal vaccine allocation for the early mitigation of pandemic influenza. PLoS computational biology, 9(3)
Auranen K, Rinta-Kokko H, Halloran ME. (2013). Estimating strain-specific and overall efficacy of polyvalent vaccines against recurrent pathogens from a cross-sectional study. Biometrics, 69(1)
Halloran ME. (2012). The Minicommunity Design to Assess Indirect Effects of Vaccination. Epidemiologic methods, 1(1)
Potter GE, Handcock MS, Longini IM Jr., Halloran ME. (2012). ESTIMATING WITHIN-SCHOOL CONTACT NETWORKS TO UNDERSTAND INFLUENZA TRANSMISSION. The annals of applied statistics, 6(1)
Vanderweele TJ, Tchetgen Tchetgen EJ, Halloran ME. (2012). Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects. Epidemiology (Cambridge, Mass.), 23(5)
Chao DL, Halstead SB, Halloran ME, Longini IM Jr.. (2012). Controlling dengue with vaccines in Thailand. PLoS neglected tropical diseases, 6(10)
Yang Y, Longini IM Jr., Halloran ME, Obenchain V. (2012). A hybrid EM and Monte Carlo EM algorithm and its application to analysis of transmission of infectious diseases. Biometrics, 68(4)
Halloran ME, Hudgens MG. (2012). Comparing bounds for vaccine effects on infectiousness. Epidemiology (Cambridge, Mass.), 23(6)
Halloran ME, Hudgens MG. (2012). Causal inference for vaccine effects on infectiousness. The international journal of biostatistics, 8(2)
Chao DL, Matrajt L, Basta NE, Sugimoto JD, Dean B, Bagwell DA, Oiulfstad B, Halloran ME, Longini IM Jr.. (2011). Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. American journal of epidemiology, 173(10)
Chao DL, Halloran ME, Longini IM Jr.. (2011). Vaccination strategies for epidemic cholera in Haiti with implications for the developing world. Proceedings of the National Academy of Sciences of the United States of America, 108(17)
Kenah E, Chao DL, Matrajt L, Halloran ME, Longini IM Jr.. (2011). The global transmission and control of influenza. PLoS One, 6(5)
Potter GE, Handcock MS, Longini IM Jr., Halloran ME. (2011). ESTIMATING WITHIN-HOUSEHOLD CONTACT NETWORKS FROM EGOCENTRIC DATA. The annals of applied statistics, 5(3)
Yang Y, Halloran ME, Daniels MJ, Longini IM Jr., Burke DS, Cummings DA. (2010). Modeling Competing Infectious Pathogens from a Bayesian Perspective: Application to Influenza Studies with Incomplete Laboratory Results. Journal of the American Statistical Association, 105(492)
Chao DL, Halloran ME, Obenchain VJ, Longini IM Jr.. (2010). FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS computational biology, 6(1)
Chao DL, Halloran ME, Longini IM Jr.. (2010). School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. The Journal of infectious diseases, 202(6)
Halloran ME. (2009). On influenza and school closings: time for prospective studies. Epidemiology (Cambridge, Mass.), 20(6)
Halloran ME, Holmes EC. (2009). Invited commentary: Evaluating vaccination programs using genetic sequence data. American journal of epidemiology, 170(12)
Basta NE, Chao DL, Halloran ME, Matrajt L, Longini IM Jr.. (2009). Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. American journal of epidemiology, 170(6)
Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM Jr.. (2009). The transmissibility and control of pandemic influenza A (H1N1) virus. Science (New York, N.Y.), 326(5953)
Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr., Dye C, Halloran ME. (2009). Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proceedings of the National Academy of Sciences of the United States of America, 106(33)
Yang Y, Halloran ME, Longini IM Jr.. (2009). A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections. Biostatistics (Oxford, England), 10(2)
Hudgens MG, Halloran ME. (2008). Toward Causal Inference With Interference. Journal of the American Statistical Association, 103(482)
Basta NE, Halloran ME, Matrajt L, Longini IM Jr.. (2008). Estimating influenza vaccine efficacy from challenge and community-based study data. American journal of epidemiology, 168(12)
Sander B, Nizam A, Garrison LP Jr., Postma MJ, Halloran ME, Longini IM Jr.. (2008). Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 12(2)
Halloran ME, Ferguson NM, Eubank S, Longini IM Jr., Cummings DA, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, Wagener D, Beckman R, Kadau K, Barrett C, Macken CA, Burke DS, Cooley P. (2008). Modeling targeted layered containment of an influenza pandemic in the United States. Proceedings of the National Academy of Sciences of the United States of America, 105(12)
Struchiner CJ, Halloran ME. (2007). Randomization and baseline transmission in vaccine field trials. Epidemiology and infection, 135(2)
Yang Y, Halloran ME, Sugimoto JD, Longini IM Jr.. (2007). Detecting human-to-human transmission of avian influenza A (H5N1). Emerging infectious diseases, 13(9)
Yang Y, Longini IM, Halloran ME. (2007). A Resampling-Based Test to Detect Person-To-Person Transmission of Infectious Disease. The annals of applied statistics, 1(1)
Yang Y, Gilbert P, Longini IM, Halloran ME. (2007). A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact. The annals of applied statistics, 2(4)
Halloran ME, Piedra PA, Longini IM Jr., Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP. (2007). Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine, 25(20)
Yang Y, Longini IM, Halloran ME. (2007). A Data-Augmentation Method for Infectious Disease Incidence Data from Close Contact Groups. Computational statistics & data analysis, 51(12)
Yang Y, Longini IM Jr., Halloran ME. (2006). Design and Evaluation of Prophylactic Interventions Using Infectious Disease Incidence Data from Close Contact Groups. Journal of the Royal Statistical Society. Series C, Applied statistics, 55(3)
Hudgens MG, Halloran ME. (2006). Causal Vaccine Effects on Binary Postinfection Outcomes. Journal of the American Statistical Association, 101(473)
Halloran ME. (2006). Invited commentary: Challenges of using contact data to understand acute respiratory disease transmission. American journal of epidemiology, 164(10)
Longini IM Jr., Halloran ME, Nizam A, Yang Y, Xu S, Burke DS, Cummings DA, Epstein JM. (2007). Containing a large bioterrorist smallpox attack: a computer simulation approach. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 11(2)
Halloran ME, Hayden FG, Yang Y, Longini IM Jr., Monto AS. (2007). Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. American journal of epidemiology, 165(2)
Halloran ME, Longini IM Jr.. (2006). Public health. Community studies for vaccinating schoolchildren against influenza. Science (New York, N.Y.), 311(5761)
Halloran ME. (2005). Overview of vaccine field studies: types of effects and designs. Journal of biopharmaceutical statistics, 16(4)
Patel R, Longini IM Jr., Halloran ME. (2005). Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. Journal of theoretical biology, 234(2)
Longini IM Jr., Halloran ME. (2005). Strategy for distribution of influenza vaccine to high-risk groups and children. American journal of epidemiology, 161(4)
Longini IM Jr., Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DA, Halloran ME. (2005). Containing pandemic influenza at the source. Science (New York, N.Y.), 309(5737)
Glezen WP, Piedra PA, Longini IM, Halloran ME. (2004). Safety of cold-adapted live influenza vaccine. The Pediatric infectious disease journal, 23(6)
Longini IM Jr., Halloran ME, Nizam A, Yang Y. (2004). Containing pandemic influenza with antiviral agents. American journal of epidemiology, 159(7)
Chu H, Halloran ME. (2004). Estimating vaccine efficacy using auxiliary outcome data and a small validation sample. Statistics in medicine, 23(17)
Chu H, Halloran ME. (2003). Bayesian estimation of vaccine efficacy. Clinical trials (London, England), 1(3)
Chu H, Préziosi MP, Halloran ME. (2004). Estimating heterogeneous transmission with multiple infectives using MCMC methods. Statistics in medicine, 23(1)
Préziosi MP, Halloran ME. (2003). Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine, 21(17-18)
Halloran ME, Longini IM Jr., Gaglani MJ, Piedra PA, Chu H, Herschler GB, Glezen WP. (2003). Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. American journal of epidemiology, 158(4)
Préziosi MP, Halloran ME. (2003). Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 37(6)
Halloran ME, Longini IM Jr., Nizam A, Yang Y. (2002). Containing bioterrorist smallpox. Science (New York, N.Y.), 298(5597)
Longini IM Jr., Halloran ME, Nizam A. (2002). Model-based estimation of vaccine effects from community vaccine trials. Statistics in medicine, 21(4)
Halloran ME, Longini IM, Cowart DM, Nizam A. (2002). Community interventions and the epidemic prevention potential. Vaccine, 20(27-28)
Halloran ME, Longini IM Jr.. (2001). Using validation sets for outcomes and exposure to infection in vaccine field studies. American journal of epidemiology, 154(5)
Stephens DS, Levin B, Halloran ME. (1998). Symposium on population biology, evolution, and control of infectious diseases. Introduction. The American journal of the medical sciences, 315(2)
Halloran ME, Anderson RM, Azevedo-Neto RS, Bellini WJ, Branch O, Burke MA, Compans R, Day K, Gooding L, Gupta S, Katz J, Kew O, Keyserling H, Krause R, Lal AA, Massad E, McLean AR, Rosa P, Rota P, Wiener P, Wynn SG, Zanetta DM. (1998). Population biology, evolution, and immunology of vaccination and vaccination programs. The American journal of the medical sciences, 315(2)
Halloran ME, Longini IM Jr., Struchiner CJ. (1998). Design and interpretation of vaccine field studies. Epidemiologic reviews, 21(1)
Longini IM Jr., Sagatelian K, Rida WN, Halloran ME. (1998). Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. Statistics in medicine, 17(10)
Bertolli J, Pangi C, Frerichs R, Halloran ME. (1997). A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar. International journal of epidemiology, 26(4)
Halloran ME, Struchiner CJ, Longini IM Jr.. (1997). Study designs for evaluating different efficacy and effectiveness aspects of vaccines. American journal of epidemiology, 146(10)
Halloran ME. (1996). Epidemiologic effects of varicella vaccination. Infectious disease clinics of North America, 10(3)
Antia R, Halloran ME. (1996). Recent developments in theories of pathogenesis of AIDS. Trends in microbiology, 4(7)
Halloran ME, Longini IM Jr., Struchiner CJ. (1996). Estimability and interpretation of vaccine efficacy using frailty mixing models. American journal of epidemiology, 144(1)
Mosure DJ, Berman S, Kleinbaum D, Halloran ME. (1996). Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis. American journal of epidemiology, 144(10)
Longini IM Jr., Datta S, Halloran ME. (1996). Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 13(5)
Haber M, Watelet L, Halloran ME. (1995). On individual and population effectiveness of vaccination. International journal of epidemiology, 24(6)
Noronha CP, Struchiner CJ, Halloran ME. (1995). Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. International journal of epidemiology, 24(5)
Halloran ME, Struchiner CJ. (1995). Causal inference in infectious diseases. Epidemiology (Cambridge, Mass.), 6(2)
Longini IM Jr., Halloran ME. (1995). AIDS: modeling epidemic control. Science (New York, N.Y.), 267(5202)
Halloran ME. (1994). Mycobacterium tuberculosis: just desserts for an ungrateful guest. Trends in ecology & evolution, 9(2)
Halloran ME, Watelet L, Struchiner CJ. (1994). Epidemiologic effects of vaccines with complex direct effects in an age-structured population. Mathematical biosciences, 121(2)
Devine OJ, Louis TA, Halloran ME. (1994). Empirical Bayes methods for stabilizing incidence rates before mapping. Epidemiology (Cambridge, Mass.), 5(6)
Halloran ME, Longini IM Jr., Haber MJ, Struchiner CJ, Brunet RC. (1994). Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field. Statistics in medicine, 13(4)
Halloran ME, Cochi SL, Lieu TA, Wharton M, Fehrs L. (1994). Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. American journal of epidemiology, 140(2)
Halloran ME. (1993). Salmonella enteritidis infections in France and the United States: causes vs causal models. American journal of public health, 83(12)
Brunet RC, Struchiner CJ, Halloran ME. (1993). On the distribution of vaccine protection under heterogeneous response. Mathematical biosciences, 116(1)
Schapira A, Beales PF, Halloran ME. (1993). Malaria: living with drug resistance. Parasitology today (Personal ed.), 9(5)
Halloran ME, Haber M, Longini IM Jr.. (1992). Interpretation and estimation of vaccine efficacy under heterogeneity. American journal of epidemiology, 136(3)
Halloran ME. (1992). Persistence, drugs and rock'n'roll. Trends in ecology & evolution, 7(7)
Halloran ME, Struchiner CJ. (1992). Modeling transmission dynamics of stage-specific malaria vaccines. Parasitology today (Personal ed.), 8(3)
Halloran ME, Struchiner CJ. (1991). Study designs for dependent happenings. Epidemiology (Cambridge, Mass.), 2(5)
Struchiner CJ, Halloran ME. (1991). Modeling AIDS vaccines: the cellular level. Memorias do Instituto Oswaldo Cruz, 87(1)
Haber M, Longini IM Jr., Halloran ME. (1991). Estimation of vaccine efficacy in outbreaks of acute infectious diseases. Statistics in medicine, 10(10)
Haber M, Longini IM Jr., Halloran ME. (1991). Measures of the effects of vaccination in a randomly mixing population. International journal of epidemiology, 20(1)
Halloran ME, Haber M, Longini IM Jr., Struchiner CJ. (1991). Direct and indirect effects in vaccine efficacy and effectiveness. American journal of epidemiology, 133(4)
Longini IM Jr., Haber MJ, Halloran ME. (1990). [Direct and indirect effects of vaccines: an annotation on the estimation of the vaccine efficacy from outbreaks caused by acute infection agents such as measles]. Boletin medico del Hospital Infantil de Mexico, 47(7)
Halloran ME, Bundy DA, Pollitt E. (1989). Infectious disease and the Unesco basic education initiative. Parasitology today (Personal ed.), 5(11)
Halloran ME, Struchiner CJ, Spielman A. (1989). Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boosting. Mathematical biosciences, 94(1)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.